Lantern Pharma Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Lantern Pharma Inc
CIK #0001763950
EDGAR Form CIK 2011 - 2026
10-K [0001763950]
10-Q [0001763950]
3 [0001763950]
4 [0001763950]
8-K [0001763950]
D [0001763950]
SC 13D [0001763950]
SC 13G [0001763950]
Form 13D/13G Filer Form 13D/13G Subject Filed
Satterfield Thomas A Jr Lantern Pharma Inc [2026-04-03]
Prophase Labs Inc Lantern Pharma Inc [2022-11-21]
Asaithambi Arunkumar Lantern Pharma Inc [2021-02-16]
Green Park & Golf Ventures LLC Lantern Pharma Inc [2021-02-16]
Empery Asset Management LP Lantern Pharma Inc [2021-01-25]
Biological Mimetics Inc Lantern Pharma Inc [2020-06-23]
BIOS Equity Partners LP Lantern Pharma Inc [2020-06-23]
Sharma Panna Lantern Pharma Inc [2020-06-19]
Form 3/4/5 Subject 2011 - 2026
Lantern Pharma
Schalop Lee Troy
Keyser D Jeffrey
Chandru Vijay
Maccecchini Maria-Luisa
Silberstein David S
Margrave David R
Bhatia Kishor G
Kreis Leslie W
Cavu Advisors LLC
BP Directors LP
Cavu Management LP
BIOS Fund II LP
Bios Equity Partners II LP
BIOS Fund II NT LP
Bios Equity Partners LP
BIOS Capital Management LP
BIOS Fund II QP LP
Fletcher Aaron GL
BIOS Advisors GP LLC
BIOS Fund I QP LP
BIOS Fund I LP
Sharma Panna
Prendergast Franklyn G
Green Park & Golf Ventures II LLC
Heighten Clay M
Green Park & Golf Ventures LLC
GPG LPI Investment LLC
Health Wildcatters Fund II LLC
Lantern 3-19 Investment LLC
Garcia Gilbert G II
Health Wildcatters LLC
Soderstrom Carl D
Asaithambi Arunkumar
Biological Mimetics Inc
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Lantern Pharma LTRN
Stock Option (Right to Buy) · derivative
2026-01-09 Grant 25,000 $0.00
Lantern Pharma LTRN
Stock Option (Right to Buy) · derivative
2026-01-09 Grant 18,460 $0.00
Lantern Pharma LTRN
Stock Option (Right to Buy) · derivative
2026-01-09 Grant 17,307 $0.00
Lantern Pharma LTRN
Stock Option (Right to Buy) · derivative
2026-01-09 Grant 25,000 $0.00
Lantern Pharma LTRN
Stock Option (Right to Buy) · derivative
2026-01-09 Grant 25,000 $0.00
Lantern Pharma LTRN
Stock Option (Right to Buy) · derivative
2026-01-09 Grant 21,152 $0.00
Lantern Pharma LTRN
Stock Option (Right to Buy) · derivative
2026-01-09 Grant 28,844 $0.00
Lantern Pharma LTRN
Stock Option (Right to Buy) · derivative
2026-01-09 Grant 25,000 $0.00
Lantern Pharma LTRN
Stock Option (Right to Buy) · derivative
2026-01-09 Grant 25,000 $0.00
Lantern Pharma LTRN
Stock Option (Right to Buy) · derivative
2026-01-09 Grant 17,307 $0.00
Lantern Pharma LTRN
Stock Option (Right to Buy) · derivative
2025-12-18 Grant 20,000 $0.00
Lantern Pharma LTRN
Stock Option (Right to Buy) · derivative
2025-12-18 Grant 10,000 $0.00
Lantern Pharma LTRN
Stock Option (Right to Buy) · derivative
2025-08-19 Grant 5,000 $0.00
Lantern Pharma LTRN
Common Stock
2025-06-13 Sell 12,319 $3.09 38,066
Lantern Pharma LTRN
Common Stock
2025-06-13 Sell 4,354 $3.09 13,454
Lantern Pharma LTRN
Common Stock
2025-06-13 Sell 1,903 $3.09 5,880
Lantern Pharma LTRN
Common Stock
2025-06-13 Sell 14,218 $3.09 43,934
Lantern Pharma LTRN
Common Stock
2025-06-13 Sell 7,206 $3.09 22,267
Lantern Pharma LTRN
Common Stock
2025-06-13 Sell 14,218 $3.09 43,934
Lantern Pharma LTRN
Common Stock
2025-06-13 Sell 12,319 $3.09 38,066
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com